- 3.4Impact Factor
- 9.9CiteScore
- 20 daysTime to First Decision
Vaccines, Volume 10, Issue 9
September 2022 - 198 articles
Cover Story: Human papillomavirus (HPV) is the most common sexually transmitted infection and is linked to several cancers. HPV vaccination is a safe and effective strategy to control HPV infection. However, in the US, HPV vaccination rates are suboptimal. More so, the onset of the COVID-19 pandemic disrupted access to preventive services. Provider recommendation is known to be the strongest predictor of vaccination. A population-based survey of providers was conducted to assess the role of recommendations on observed changes in acceptance of HPV vaccination in the context of the COVID-19 pandemic. This study highlights the importance of provider recommendations on HPV vaccination acceptance despite the disruptive effect of the pandemic. Providers should continue to recommend HPV vaccination at every visit to increase uptake. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Vaccines - ISSN 2076-393XCreative Common CC BY license